Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Gastrointestinal 2 Other 1 Breast 1

Conditions

Breast Neoplasms 2768 Triple Negative Breast Neoplasms 406 Neoplasm Metastasis 156 Breast Neoplasms, Male 102 Neoplasms 100 Ovarian Neoplasms 69 Carcinoma, Non-Small-Cell Lung 68 Carcinoma, Intraductal, Noninfiltrating 68 Lung Neoplasms 66 Brain Neoplasms 60 Colorectal Neoplasms 52 Inflammatory Breast Neoplasms 50 Advanced Breast Cancer 49 Breast Carcinoma In Situ 47 Prostatic Neoplasms 42 Melanoma 38 Pancreatic Neoplasms 37 Stomach Neoplasms 32 Uterine Cervical Neoplasms 28 Sarcoma 27 HER2-positive Breast Cancer 27 Endometrial Neoplasms 25 Head and Neck Neoplasms 24 Recurrence 23 Colonic Neoplasms 22 Carcinoma, Renal Cell 21 Carcinoma, Ovarian Epithelial 21 Small Cell Lung Carcinoma 20 Multiple Myeloma 20 Carcinoma, Ductal, Breast 20

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophagitis × Breast × Clear all

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡